Tuesday Nov 19
Skyepharma PLC's Partner Kyorin Launches Flutiform In Japan
LONDON, UK, 19 November, 2013 - Skyepharma PLC , the expert oral and inhalation drug delivery company, today announces that flutiform has been launched in Japan following agreement on pricing reimbursement.
Hong Kong Authority Approves Mundipharma AG's Flutiform...
Hong Kong Authority Approves flutiform , a New Treatment for Asthma HONG KONG, Nov. 8, 2013 /PRNewswire/ -- Mundipharma announced today that flutiform , a new combination therapy for the maintenance treatment of asthma, is now available for use in Hong Kong.
FDA Sends Sunovion Letter Regarding Brovana Brochure
The FDA today posted on its website a letter sent to Sunovion Pharmaceuticals regarding a patient brochure for COPD drug Brovana.
Boehringer Ingelheim to Present Latest Data from Robust Respiratory...
These data exemplify Boehringer Ingelheim's continued commitment to lung health and to discovering new therapies for patients and physicians where unmet needs exist.
Skyepharma PLC ??? Interim Management Statement
LONDON, UK, 10 October, 2013 - Skyepharma PLC , the expert oral and inhalation drug delivery company, today publishes its Interim Management Statement for the period 1 July 2013 to 9 October 2013 and provides an update on key events since the half-year results announced on 15 August 2013.